Leili Aghebati‐Maleki

8.8k total citations · 2 hit papers
219 papers, 6.4k citations indexed

About

Leili Aghebati‐Maleki is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Leili Aghebati‐Maleki has authored 219 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Immunology, 79 papers in Molecular Biology and 37 papers in Oncology. Recurrent topics in Leili Aghebati‐Maleki's work include Reproductive System and Pregnancy (51 papers), Monoclonal and Polyclonal Antibodies Research (27 papers) and Immunotherapy and Immune Responses (22 papers). Leili Aghebati‐Maleki is often cited by papers focused on Reproductive System and Pregnancy (51 papers), Monoclonal and Polyclonal Antibodies Research (27 papers) and Immunotherapy and Immune Responses (22 papers). Leili Aghebati‐Maleki collaborates with scholars based in Iran, Sweden and Hungary. Leili Aghebati‐Maleki's co-authors include Mehdi Yousefi, Ali Aghebati‐Maleki, Majid Ahmadi, Behzad Baradaran, Sanam Dolati, Hossein Samadi Kafil, Amin Abbasi, Mohammad Nouri, Jafar Majidi and Farhad Jadidi‐Niaragh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Leili Aghebati‐Maleki

202 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers

2019 328 citations Ali Aghebati‐Maleki, Majid Ahmadi et al. profile →
The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies

2023 124 citations Amin Daei Sorkhabi, Leila Mohamed Khosroshahi et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leili Aghebati‐Maleki Iran	47	2.4k	1.9k	954	673	652	219	6.4k
Mohammad Nouri Iran	46	2.4k 1.0×	1.4k 0.7×	532 0.6×	1.1k 1.7×	624 1.0×	272	6.6k
Farhad Jadidi‐Niaragh Iran	53	2.9k 1.2×	3.3k 1.8×	1.9k 2.0×	445 0.7×	333 0.5×	211	8.3k
Mahmood Jeddi‐Tehrani Iran	42	1.7k 0.7×	2.5k 1.3×	871 0.9×	632 0.9×	437 0.7×	292	5.8k
Tomoyuki Fujii Japan	49	1.6k 0.7×	2.8k 1.5×	602 0.6×	1.5k 2.2×	2.4k 3.7×	395	8.1k
Maria Gazouli Greece	46	3.1k 1.3×	807 0.4×	1.0k 1.1×	365 0.5×	131 0.2×	357	7.6k
Majid Ahmadi Iran	40	1.3k 0.5×	1.3k 0.7×	454 0.5×	377 0.6×	443 0.7×	103	4.2k
Xia Zhao China	40	3.5k 1.4×	1.2k 0.7×	1.5k 1.6×	183 0.3×	167 0.3×	104	7.4k
Lu Li China	42	2.3k 0.9×	1.2k 0.7×	547 0.6×	246 0.4×	88 0.1×	329	6.1k
Amir‐Hassan Zarnani Iran	35	1.1k 0.4×	1.4k 0.7×	322 0.3×	558 0.8×	617 0.9×	218	4.2k
Ning Xu China	39	2.5k 1.0×	1.2k 0.7×	660 0.7×	306 0.5×	91 0.1×	125	6.5k

Countries citing papers authored by Leili Aghebati‐Maleki

Since Specialization

Citations

This map shows the geographic impact of Leili Aghebati‐Maleki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leili Aghebati‐Maleki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leili Aghebati‐Maleki more than expected).

Fields of papers citing papers by Leili Aghebati‐Maleki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leili Aghebati‐Maleki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leili Aghebati‐Maleki. The network helps show where Leili Aghebati‐Maleki may publish in the future.

Co-authorship network of co-authors of Leili Aghebati‐Maleki

This figure shows the co-authorship network connecting the top 25 collaborators of Leili Aghebati‐Maleki. A scholar is included among the top collaborators of Leili Aghebati‐Maleki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leili Aghebati‐Maleki. Leili Aghebati‐Maleki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Soltani‐Zangbar, Mohammad Sadegh, et al.. (2025). Immunoglobulin therapy for infertility and the role of immune cells in pregnancy success: An extensive investigation and update. Journal of Reproductive Immunology. 169. 104458–104458. 1 indexed citations

Sharifi, Parisa, Amir Moradi, Amin Kamrani, et al.. (2025). The effect of vitamin D supplementation and vaginal probiotics on fertility in women with recurrent implantation failure: A randomized clinical trial. Human Immunology. 86(3). 111259–111259. 2 indexed citations

Safaei, Sahar, et al.. (2025). The role of cytokines in shaping the future of Cancer immunotherapy. Cytokine. 189. 156888–156888. 3 indexed citations

Hosseini, Maryam, Mahdi Bagheri, Mohammad Sadegh Soltani‐Zangbar, et al.. (2024). The effectiveness of ruxolitinib and cyclophosphamide combination on T helper 17 and regulatory T cells in rat experimental membranous glomerulonephritis. Molecular and Cellular Probes. 76. 101969–101969.

Abdolmohammadi‐Vahid, Samaneh, et al.. (2024). P-395 Vaginal probiotics and vitamin D, as immunomodulatory approaches in improving the implantation and live birth in repeated implantation failure (RIF) women with imbalanced immune system. Human Reproduction. 39(Supplement_1). 1 indexed citations

Baradaran, Behzad, et al.. (2024). Altered gene expression of miR-155 in peripheral blood mononuclear cells of Multiple sclerosis patients: Correlation with TH17 frequency, inflammatory cytokine profile and autoimmunity. Multiple Sclerosis and Related Disorders. 89. 105764–105764. 4 indexed citations

Mardi, Amirhossein, et al.. (2024). CTLA-4 silencing could promote anti-tumor effects in hepatocellular. Medical Oncology. 41(8).

Masoumi, Javad, Farid Ghorbaninezhad, Leili Aghebati‐Maleki, et al.. (2024). Boosting immunotherapy efficacy: Empowering the Potency of Dendritic cells loaded with breast cancer lysates through CTLA-4 suppression. Heliyon. 10(18). e37699–e37699. 2 indexed citations

Soltani‐Zangbar, Mohammad Sadegh, Mahsa Hajivalili, Leili Aghebati‐Maleki, et al.. (2023). SARS-CoV2 infection induce miR-155 expression and skewed Th17/Treg balance by changing SOCS1 level: A clinical study. Cytokine. 169. 156248–156248. 14 indexed citations

10.

Sorkhabi, Amin Daei, Leila Mohamed Khosroshahi, Aila Sarkesh, et al.. (2023). The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies. Frontiers in Immunology. 14. 1113882–1113882. 124 indexed citations breakdown →

11.

Parhizkar, Forough, et al.. (2023). Autophagy-mediated immune system regulation in reproductive system and pregnancy-associated complications. Journal of Reproductive Immunology. 158. 103973–103973. 7 indexed citations

12.

Soltani‐Zangbar, Mohammad Sadegh, Leili Aghebati‐Maleki, Forough Parhizkar, et al.. (2022). Evaluation of CD39, CD73, HIF-1α, and their related miRNAs expression in decidua of preeclampsia cases compared to healthy pregnant women. Molecular Biology Reports. 49(11). 10183–10193. 10 indexed citations

13.

Ghorbani, Farzaneh, Majid Ahmadi, Ali Aghebati‐Maleki, et al.. (2022). Evaluating the effects of autologous platelet lysate on gene expression of bone growth factors and related cytokines secretion in rabbits with bone fracture. Gene Reports. 28. 101658–101658. 1 indexed citations

14.

Rad, Aziz Homayouni, Leili Aghebati‐Maleki, Hossein Samadi Kafil, et al.. (2021). Postbiotics, as Dynamic Biomolecules, and Their Promising Role in Promoting Food Safety. Biointerface Research in Applied Chemistry. 11(6). 14529–14544. 55 indexed citations

15.

Aghebati‐Maleki, Ali, Behzad Baradaran, Khalil Hajiasgharzadeh, Babak Bakhshinejad, & Leili Aghebati‐Maleki. (2021). The Application of Next Generation Sequencing in Phage Display: A Short Review. SHILAP Revista de lepidopterología. 1(1). 7–7.

16.

Hamishehkar, Hamed, Behzad Baradaran, Siamak Sandoghchian Shotorbani, et al.. (2021). Antifungal Effects of Voriconazole-Loaded Nano-Liposome on Fluconazole - Resistant Clinical Isolates of Candida albicans , Biological Activity and ERG11, CDR1, and CDR2 Gene Expression. Assay and Drug Development Technologies. 19(7). 453–462. 12 indexed citations

17.

Rad, Aziz Homayouni, et al.. (2020). Postbiotics as novel health-promoting ingredients in functional foods. Health Promotion Perspectives. 10(1). 3–4. 80 indexed citations

18.

Soltani‐Zangbar, Mohammad Sadegh, Amin Kamrani, Ramyar Azizi, et al.. (2019). Oxidative stress, inflammatory settings, and microRNA regulation in the recurrent implantation failure patients with metabolic syndrome. American Journal of Reproductive Immunology. 82(4). e13170–e13170. 43 indexed citations

19.

Aghebati‐Maleki, Leili, Mahdi Shabani, Behzad Baradaran, et al.. (2017). Receptor tyrosine kinase-like orphan receptor 1 (ROR-1): An emerging target for diagnosis and therapy of chronic lymphocytic leukemia. Biomedicine & Pharmacotherapy. 88. 814–822. 23 indexed citations

20.

Motallebnezhad, Morteza, Vahid Younesi, Leili Aghebati‐Maleki, et al.. (2016). Antiproliferative and apoptotic effects of a specific anti-insulin-like growth factor I receptor single chain antibody on breast cancer cells. Tumor Biology. 37(11). 14841–14850. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact